ReviewCancers2023

CDK4/6 Inhibitors-Overcoming Endocrine Resistance Is the Standard in Patients with Hormone Receptor-Positive Breast Cancer.

Naiba Nabieva et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.